Institutional Manager · CIK 0002104501
Remedium Capital Partners, LLC
FORT LAUDERDALE, FL · File #028-26277
Latest AUM
$170,211
Positions
6
Top-10 Concentration
100.0%
Filings
1
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| NEW | Spyre Therapeutics Inc | SYRE | +1,456,231 | +$47,706 | $0 |
| NEW | Oruka Therapeutics Inc | ORKA | +1,552,414 | +$47,054 | $0 |
| NEW | Apogee Therapeutics Inc | APGE | +583,591 | +$44,050 | $0 |
| NEW | Jade Biosciences Inc | JBIO | +1,577,750 | +$24,345 | $0 |
| NEW | Crescent Biopharma Inc | CBIO | +361,250 | +$4,284 | $0 |
| NEW | Galecto Inc | 36322Q206 | +120,473 | +$2,772 | $0 |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 20256 pos · $170,211
Top 6 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | Spyre Therapeutics Inc | SYRE | 1,456,231 | $47,706 | 28.03% |
| 2 | Oruka Therapeutics Inc | ORKA | 1,552,414 | $47,054 | 27.64% |
| 3 | Apogee Therapeutics Inc | APGE | 583,591 | $44,050 | 25.88% |
| 4 | Jade Biosciences Inc | JBIO | 1,577,750 | $24,345 | 14.30% |
| 5 | Crescent Biopharma Inc | CBIO | 361,250 | $4,284 | 2.52% |
| 6 | Galecto Inc | 36322Q206 | 120,473 | $2,772 | 1.63% |